Clofibrate

  • TRADE NAMES: Abitrate; Atromid-S (Wyeth); Claripex; Col; Lipavlon; Novo-Fibrate; Regelan N; Skleromexe
  • INDICATIONS: Type III hyperlipidemia
  • CLASS: Fibrate
  • HALF-LIFE: 6–25 hours after a single dose
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Anisindione, Anticoagulants, Dicumarol, Gliclazide, Ursodiol, Warfarin

PREGNANCY CATEGORY: C

Our database has 22 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.


Page last updated 07/31/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top